ElaineYChengMD

PubMed

• Coffee makes everything better … ….
  Elaine Y Cheng, Leon Kushnir
  American Journal of Surgery. 2023-08-01
• 1 citations
  Differential cytokine and chemokine expression during rejection and infection following intestinal transplantation
  Emily C. Whang, Maura Rossetti, Marjorie-Anne R. Guerra, Elaine Y. Cheng, Elizabeth A. Marcus
  Transplant Immunology. 2021-08-13
• 1 citations
  Perforated Carcinoid Tumor of the Appendix: Need for Guidelines for Management With Respect to Prognostic Factors:
  Charles McCann, Jandie Schwartz, Luke Perry, Elaine Cheng
  The American Surgeon. 2021-01-27

Journal Articles

• Obliterative Portal Venopathy: A Histopathologic Finding Associated with Chronic Antibody‐Mediated Rejection in Pediatric Liver Allografts  
  Jason V Scapa, Robert S Venick, Laura J Wozniak, Douglas G Farmer, Jorge H Vargas, Bita V Naini, Ronald W Busuttil, Elaine Y Cheng, Pediatric Transplantation
• Clinical characteristics and outcomes of PTLD following intestinal transplantation  
  Wozniak LJ, Mauer TL, Venick RS, Said JW, Kao RL, Kempert P, Marcus EA, Hwang V, Cheng EY, Busuttil RW, McDiarmid SV, Farmer DG, Clin Transplant, 1/1/2018
• The role of humoral alloreactivity in liver transplantation: Lessons learned and new perspectives  
  Cheng EY, J Immunol Res, 1/1/2017
• Evaluation of patients with hepatocellular carcinomas that do not produce alpha-Fetoprotein  
  Agopian VG, Harlander-Locke MP, Markovic D, Zarrinpar A, Kaldas FM, Cheng EY, Yersiz H, Farmer DG, Hiatt JR, Busuttil RW, JAMA Surg, 1/1/2017
• Prevalence and clinical impact of donor-29888807specific alloantibody among intestinal transplant recipients  
  Cheng EY, Everly MJ, Kaneku H, Banuelos N, Wozniak LJ, Venick RS, Marcus EA, McDiarmid SV, Busuttil RW, Terasaki PI, Farmer DG, Transplantation, 1/1/2017
• The impact of antibodies and virtual crossmatching on intestinal transplant outcomes  
  Cheng EY, DuBray BJ, Farmer DG, Curr Opin Organ Transplant, 1/1/2017
• Paritaprevir/ritonavir/ombitasvir and dasabuvir in the treatment of chronic hepatitis C virus infection  
  Cheng EY, Saab S, Holt C, Busuttil RW, Expert Opinion on Pharmacotherapy, 1/1/2015
• Case Report: Successful term pregnancy in an intestine-pancreas transplant recipient with chronic graft dysfunction and parenteral nutrition dependence  
  Marcus EA, Wozniak LJ, Venick RS, Ponthieux SM, Cheng EY, Farmer DG, Transplantation Proceedings, 1/1/2015
• MELD exceptions for hepatocellular carcinoma: Regional variations in the impact of the Share 35 liver allocation policy  
  Cheng EY, Clinical Transplants, 1/1/2015
• Liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma � Out of the Unknown  
  Cheng, EY, Busuttil RW, JAMA Surgery, 1/1/2015
• Is ABO-compatible but non-identical intestinal transplant comparable to ABO-identical transplant? An analysis of the UNOS registry  
  Cai J, Qing X, Wu G, Everly M, Cheng EY, Terasaki P, SOJ Immunology, 1/1/2015
• Tolerogenic mechanisms in liver transplantation  
  Cheng EY, Terasaki PI, SOJ Immunology, 1/1/2015
• The role of donor-specific antibodies in intestinal transplantation: Experience at University of California-Los Angeles and literature review  
  Cheng EY, Kaneku H, Farmer DG, Clinical Transplants, 1/1/2014
• Trends of immunosuppression and outcomes following liver transplantation: An analysis of the UNOS registry  
  Cheng EY, Everly MJ, Clinical Transplants, 1/1/2014
• Organ Procurement and Transplantation Network/Scientific Registry of Transplant Recipients 2014 Data Report: Intestine  
  Cai J, Wu G, Qing A, Everly M, Cheng EY, Terasaki PI, Clinical Transplants, 1/1/2014
• Renal allograft outcomes following early corticosteroid withdrawal in Hispanic transplant patients  
  Afaneh C, Cheng EY, Aull MJ, Watkins AC, Kim J, Leeser DB, Kapur S, Clinical Transplantation, 1/1/2013
• Isolation of Clostridium difficile from Peritoneal Fluid  
  Nissan D, Castillo M, Cheng EY, Eachempati S, Barie PS, Surgical Infections, 1/1/2012
• Dendritic cells with TGF-b1 and IL-2 differentiate na�ve CD4+ T cells into alloantigen-specific and allograft protective Foxp3+ regulatory T cells  
  Yang H, Cheng EY, Sharma VK, Lagman M, Chang C, Song P, Ding R, Muthukumar T, Suthanthiran M, Transplantation, 1/1/2012
• Cecal diverticulitis as a continuing diagnostic and management dilemma: a report of two cases in children  
  Cheng EY, Cohen L, Gasinu S, Sy C, Beneck D, Spigland N, Pediatric Surgery International, 1/1/2012
• Another case of cecal diverticulitis  
  Rich BS, Cheng EY, Cohen L, Sy C, Spigland N, Pediatric Surgery International, 1/1/2012
• Bacterial breakaway  
  Cheng EY, Science Translational Medicine, 1/26/2011
• Too much of a good thing?  
  Cheng EY, Science Translational Medicine, 1/5/2011
• Tumor imaging: surgeons can have it all  
  Cheng EY, Science Translational Medicine, 1/31/2010
• Licensed to enter  
  Cheng EY, Science Translational Medicine, 1/27/2010
• Obesity and inflammation: the Fas connection  
  Cheng EY, Science Translational Medicine, 1/27/2010
• Join now to see all

Books/Book Chapters

• Solid Organ Transplantation in Infants and Children. 
  Chapter: Post-operative care of the intestinal transplant recipient: Graft monitoring, nutrition, and management of medical complications. 
  Cheng EY, Venick RSEditors: Dunn S.Springer, New York, NY2018
• Optimal Resources for Surgical Quality and Safety. 
  Chapter: Disease management / multidisciplinary patient care - Transplant. 
  Hirose R, Cheng EY, Busuttil RWEditors: Hoyt DB and Ko CY.American College of Surgeons2017
• Disease Recurrence after Liver Transplantation. 
  Chapter: Recurrence of disease after liver transplantation in the pediatric population. 
  Cheng EY, Venick RS, Busuttil RWEditors: Thuluvath P.Springer, New York, NY2015
• Schwartz�s Principles of Surgery 
  Chapter: Liver. 
  Cheng EY, Zarrinpar A, Gellar DA, Goss JA, Busuttil RWEditors: Brunicardi FC, Andersen DK, Billiar TR, Dunn DL, Hunter JG, Matthews JB, Pollock RE.McGraw Hill, New York, NYEdition 10th,2015
• Current Surgical Therapy. 
  Chapter: Portal hypertension: The role of shunting procedures. 
  Cheng EY, Hiatt JR, Busuttil RWEditors: Cameron JL and Cameron AM.Saunders, Philadelphia, PA2013
• Join now to see all

Abstracts/Posters

• Excellent survival outcomes following liver transplantation in patients with chronic liver disease complicated by hepatopulmonary syndrome.
  Cheng EY, Yu DH, Agopian VG, Busuttil RW, Wang TS, 87th Annual Meeting of the Pacific Coast Surgical Association, HI, 1/1/2016
• Radiographically apparent non-alphafetoprotein producing hepatocellular carcinoma: Should transplant prioritization remain the same? A single center analysis of 665 li...
  Agopian VG, Harlander-Locke M, Markovic D, Zarrinpar A, Kaldas FM, Cheng EY, Yersiz H, Farmer DG, Hiatt JR, Busuttil RW, 87th Annual Meeting of the Pacific Coast Surgical Association, HI, 1/1/2016
• Impact of the Share 35 liver allocation policy on candidates with MELD exception scores.
  Cheng EY, Everly MJ, 26th International Congress of The Transplantation Society, Hong Kong, 1/1/2016
• Clinical predictors of mortality and hospital length of stay in patients with hepatopulmonary syndrome (HPS) undergoing orthotopic liver transplantation.
  Yu D, Lam K, Charan D, Hu S, Cheng EY, Wang T, American Thoracic Society International Conference, Denver, CO, 1/1/2015
• Pediatric intestinal transplant recipients a decade or more later: a detailed nutrition, developmental and psychosocial report.
  Venick RS, Wozniak LJ, Marcus EA, Cheng EY, Hwang V, Crowley S, Beckwith P, McDiarmid SV, Busuttil RW, Farmer DG, XIV International Small Bowel Transplant Symposium, Buenos Aires, Argentina, 1/1/2015
• A single center analysis of reoperative frequency following intestinal transplantation.
  Marcus EA, Li N, Cheng EY, Wozniak LJ, Venick RS, Farmer DG, XIV International Small Bowel Transplant Symposium, Buenos Aires, Argentina, 1/1/2015
• Outcomes after intestinal transplantation: Results from a large single center review.
  Farmer DG, Cheng EY, Wozniak LJ, Marcus EA, Hwang V, Crowley S, Yersiz H, Busuttil RW, McDiarmid SV, Venick RS, XIV International Small Bowel Transplant Symposium, Buenos Aires, Argentina, 1/1/2015
• Removal of donor-specific antibodies after intestinal transplantation.
  Cheng EY, Wozniak LJ, Venick RS, Marcus EA, Hwang V, Crowley S, Everly MJ, Terasaki PI, McDiarmid SV, Farmer DG, XIV International Small Bowel Transplant Symposium, Buenos Aires, Argentina, 1/1/2015
• Clinical impact of donor-specific antibodies on intestinal allograft rejection and survival.
  Cheng EY, Wozniak LJ, Venick RS, Marcus EA, Hwang V, Crowley S, Everly MJ, Terasaki PI, McDiarmid SV, Farmer DG, XIV International Small Bowel Transplant Symposium, Buenos Aires, Argentina, 1/1/2015
• The pancreas as a component of the multivisceral allograft: Posttransplant function and complications.
  Cheng EY, Venick RS, Wozniak LJ, Marcus EA, Hwang V, Crowley S, Yersiz H, McDiarmid SV, Farmer DG, XIV International Small Bowel Transplant Symposium, Buenos Aires, Argentina, 1/1/2015
• The use of interleukin-2 receptor antagonists for induction therapy in intestinal transplantation.
  Cheng EY, Venick RS, Marcus EA, Wozniak LJ, McDiarmid SV, Hwang V, Crowley S, Busuttil RW, Farmer DG, XIV International Small Bowel Transplant Symposium, Buenos Aires, Argentina, 1/1/2015
• Why the surge in PTLD? An update on PTLD following intestinal transplantation.
  Wozniak LJ, Mauer TL, Venick RS, Kempert P, Marcus EA, Hwang V, Cheng EY, McDiarmid SV, Farmer DG, XIV International Small Bowel Transplant Symposium, Buenos Aires, Argentina, 1/1/2015
• Prediction of futility following liver transplantation: A blinded, prospective comparison of risk-scoring systems.
  Cheng EY, Agopian V, Petrowsky H, DiNorcia J, Shaik I, Farmer D, Busuttil R, American Society of Transplant Surgeons 14th Annual State of the Art Winter Symposium, Miami, FL, 1/1/2014
• A rapid, reproducible, non-invasive predictor of liver graft utilization.
  Zarrinpar A, Lee C, Noguchi E, Cheng EY, DiNorcia J, Shaik I, Agopian V, Yersiz H, Kaldas F, Farmer D, Busuttil R, American Society of Transplant Surgeons 14th Annual State of the Art Winter Symposium, Miami, FL, 1/1/2014
• Predictors of graft nonfunction (GNF) following orthotopic liver transplantation: A single-center analysis of 1519 consecutive transplants.
  Shaik I, DiNorcia J, Cheng EY, Kaldas F, Farmer D, Zarrinpar A, Busuttil R, Agopian V, American Society of Transplant Surgeons 14th Annual State of the Art Winter Symposium, Miami, FL, 1/1/2014
• Reoperative complications after primary orthotopic liver transplantation: predictors and outcomes.
  DiNorcia J, Cheng EY, Shaik I, Zarrinpar A, Kaldas F, Yersiz H, Farmer D, Busuttil R, Agopian V, Pacific Coast Surgical Association 84th Annual Meeting, Dana Point, CA, 1/1/2014
• Predictors of poor outcomes following liver transplantation in patients with hepatopulmonary syndrome.
  Cheng EY, Zopey R, Wang T, Busuttil RW, American Transplant Congress, Seattle, WA, 1/1/2013
• Body mass index is not a significant predictor of costs in renal transplantation.
  Nugent WC, Cheng EY, Afaneh C, Halpern J, Aull M, Figuiero J, Leeser DB, Kapur S, American Transplant Congress, San Diego, CA, 1/1/2010
• A new strategy to minimize islet cell mass in type 1 diabetic recipients: Diannexin improves early graft function in the marginal mass islet transplantation model.
  Cheng EY, Yang H, Sharma VK, Lagman M, Leeser DB, Suthanthiran M, American Transplant Congress, San Diego, CA, 1/1/2010
• Renal transplant outcomes in obese recipients under immunosuppression with early corticosteroid withdrawal.
  Cheng EY, Halpern J, Afaneh C, Aull M, Figuiero J, Leeser DB, Kapur S, American Transplant Congress, San Diego, CA, 1/1/2010
• Steroid avoidance in 2-haplotype matched living donor renal transplants with basiliximab induction therapy.
  Afaneh C, Halpern J, Cheng EY, Aull M, Figuiero J, Leeser DB, Kapur S, American Transplant Congress, San Diego, CA, 1/1/2010
• Systemic TGF-beta1 gene therapy induces Foxp3+ regulatory T cells and retards the development of autoimmune diabetes in nonobese diabetic mice.
  Yang H, Cheng EY, Hancock WW, Suthanthiran M, XXIII International Congress of the Transplantation Society, Vancouver, 1/1/2010
• Development of a new strategy for minimizing islet cell mass in type 1 diabetic recipients: Diannexin reduces proapoptotic Bid, promotes anti-inflammatory interleukin-...
  Cheng EY, Yang H, Sharma VK, Lagman M, Leeser DB, Suthanthiran M, XXIII International Congress of the Transplantation Society, Vancouver, 1/1/2010
• Cheng EY, Weir R, Lagman M, Sharma VK, Suthanthiran M, Yang H, Am J Transpl; American Transplant Congress, Boston, MA, 1/1/2009
• Successful laparoscopic donor nephrectomies performed without intraoperative use of intravenous heparin.
  Cheng EY, Leeser D, Aull M, Figueiro J, Kapur S, Del Pizzo J, Am J Transpl; American Transplant Congress, Boston, MA, 1/1/2009
• Join now to see all

Lectures

• Intestinal failure management and adaptation: When to call the surgeon? 
  Newport Beach, CA - 1/7/2016
• Quality improvement processes and departmental quarterly report. 
  Weill Cornell Medical College, New York, NY - 1/11/2012
• A clinically adaptable strategy for islet pancreatic islet cell transplantation. 
  Weill Cornell Medical College, New York, NY - 1/4/2012